These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 20183466)

  • 21. How can I deal with missing data in my study?
    Bennett DA
    Aust N Z J Public Health; 2001 Oct; 25(5):464-9. PubMed ID: 11688629
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intent-to-randomize corrections for missing data resulting from run-in selection bias in clinical trials for chronic conditions.
    Berger VW; Vali B
    J Biopharm Stat; 2011 Mar; 21(2):263-70. PubMed ID: 21391000
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The analysis, interpretation, and presentation of quality of life data.
    Stephens R
    J Biopharm Stat; 2004 Feb; 14(1):53-71. PubMed ID: 15027500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Propensity score estimation with missing values using a multiple imputation missingness pattern (MIMP) approach.
    Qu Y; Lipkovich I
    Stat Med; 2009 Apr; 28(9):1402-14. PubMed ID: 19222021
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An extended general location model for causal inferences from data subject to noncompliance and missing values.
    Peng Y; Little RJ; Raghunathan TE
    Biometrics; 2004 Sep; 60(3):598-607. PubMed ID: 15339281
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Making sense of noninferiority: a clinical and statistical perspective on its application to cardiovascular clinical trials.
    Kaul S; Diamond GA
    Prog Cardiovasc Dis; 2007; 49(4):284-99. PubMed ID: 17185116
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [On the problem of missing data: How to identify and reduce the impact of missing data on findings of data analysis].
    Wirtz M
    Rehabilitation (Stuttg); 2004 Apr; 43(2):109-15. PubMed ID: 15100920
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Subgroup analyses in randomized clinical trials: statistical and regulatory issues.
    Grouin JM; Coste M; Lewis J
    J Biopharm Stat; 2005; 15(5):869-82. PubMed ID: 16078390
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Robustness assessments are needed to reduce bias in meta-analyses that include zero-event randomized trials.
    Keus F; Wetterslev J; Gluud C; Gooszen HG; van Laarhoven CJ
    Am J Gastroenterol; 2009 Mar; 104(3):546-51. PubMed ID: 19262513
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An orwellian discourse on the meaning and measurement of noninferiority.
    Diamond GA; Kaul S
    Am J Cardiol; 2007 Jan; 99(2):284-7. PubMed ID: 17223435
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stratified tests, stratified slopes, and random effects models for clinical trials with missing data.
    Dawson JD; Han SH
    J Biopharm Stat; 2000 Nov; 10(4):447-55. PubMed ID: 11104386
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Size and power of two-sample tests of repeated measures data.
    Dawson JD; Lagakos SW
    Biometrics; 1993 Dec; 49(4):1022-32. PubMed ID: 7906957
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In a randomized controlled trial, missing data led to biased results regarding anxiety.
    Ross L; Thomsen BL; Boesen EH; Johansen C
    J Clin Epidemiol; 2004 Nov; 57(11):1131-7. PubMed ID: 15567628
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methods for the analysis of binary outcome results in the presence of missing data.
    Delucchi KL
    J Consult Clin Psychol; 1994 Jun; 62(3):569-75. PubMed ID: 8063983
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Misuse of baseline comparison tests and subgroup analyses in surgical trials.
    Bhandari M; Devereaux PJ; Li P; Mah D; Lim K; Schünemann HJ; Tornetta P
    Clin Orthop Relat Res; 2006 Jun; 447():247-51. PubMed ID: 16672904
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An overview of practical approaches for handling missing data in clinical trials.
    DeSouza CM; Legedza AT; Sankoh AJ
    J Biopharm Stat; 2009 Nov; 19(6):1055-73. PubMed ID: 20183464
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intention-to-treat analyses for incomplete repeated measures data.
    Hogan JW; Laird NM
    Biometrics; 1996 Sep; 52(3):1002-17. PubMed ID: 8805765
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The intention-to-treat approach in randomized controlled trials: are authors saying what they do and doing what they say?
    Gravel J; Opatrny L; Shapiro S
    Clin Trials; 2007; 4(4):350-6. PubMed ID: 17848496
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estimation of the risk difference under a noncompliance randomized clinical trial with missing outcomes.
    Lui KJ
    J Biopharm Stat; 2008; 18(2):273-92. PubMed ID: 18327721
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Statistical analysis and handling of missing data in cluster randomized trials: a systematic review.
    Fiero MH; Huang S; Oren E; Bell ML
    Trials; 2016 Feb; 17():72. PubMed ID: 26862034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.